Related Experiment Videos
Application of an in vitro system in the study of chemotherapeutic drug effects on DNA replication
M J Diaz-Perez1, I W Wainer, M Zannis-Hadjopoulos
1Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Abstract:
DNA replication machinery is an important target for chemotherapeutic drugs. We have used an in vitro system to study the effect of drugs on mammalian DNA replication, either by direct interaction with the DNA structure or with replication proteins and machinery. The anthracycline doxorubicin (Dox) showed a dose-dependent inhibitory effect on DNA replication, whether incubated with HeLa cell extracts or with DNA and nucleotides. Earliest-labeled fragment analysis revealed that inhibition of replication began within the origin-containing fragment in both control and Dox-containing reactions in vitro. AraC, a nucleoside analog, had no significant effect on DNA synthesis. In contrast, araCTP was able to inhibit DNA replication in vitro. Since metabolism is diminished in this in vitro system, the degree of phosphorylation of araC was apparently low. Progesterone showed an increase in nucleotide incorporation (sensitive to BuPdGTP inhibition of replication-specific polymerases alpha and delta) after preincubation with HeLa cell extracts, although progesterone receptors were not detectable in the HeLa cell extracts. In addition, we observed an inhibition in DNA replication when progesterone was preincubated with DNA and nucleotides. These results suggest that progesterone may have a mechanism of action that is different from any known to be mediated through progesterone receptors. In conclusion, these results indicate that this mammalian in vitro replication system will be useful for the study of mechanisms and design of therapeutic drugs that inhibit mammalian DNA replication.
Insights
This study investigated drug effects on mammalian DNA replication using an in vitro system. Doxorubicin (Dox) inhibited replication, while progesterone showed complex effects, suggesting novel therapeutic targets for DNA replication inhibitors.
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- DNA replication is a critical target for cancer chemotherapy.
- Understanding drug interactions with replication machinery is essential for developing new therapies.
Purpose of the Study:
- To evaluate the effects of doxorubicin (Dox), AraC, and progesterone on mammalian DNA replication in vitro.
- To investigate the mechanisms of drug action on DNA replication machinery.
- To assess the utility of an in vitro system for drug discovery targeting DNA replication.
Main Methods:
- Utilized a mammalian in vitro DNA replication system with HeLa cell extracts, DNA, and nucleotides.
- Analyzed drug effects on DNA synthesis and replication origins.
- Examined drug metabolism and phosphorylation in the in vitro system.
Main Results:
- Doxorubicin demonstrated a dose-dependent inhibition of DNA replication, affecting origin fragments.
- AraCTP inhibited DNA replication, whereas AraC had no significant effect, indicating low phosphorylation in vitro.
- Progesterone exhibited dual effects: enhancing nucleotide incorporation with cell extracts and inhibiting replication with DNA/nucleotides, suggesting a non-receptor-mediated mechanism.
Conclusions:
- The in vitro system effectively models drug interactions with DNA replication machinery.
- Doxorubicin's inhibitory mechanism on DNA replication was confirmed in vitro.
- Progesterone's novel inhibitory action on DNA replication warrants further investigation for therapeutic potential.